PTGS2 and neoplasm: In contrast, mice implanted with COX-2-knockdown HepG2-Cas9-PTGS2 cells showed slower tumor growth, a smaller size, and lower tumor weight than mice implanted with HepG2-Cas9-NC cells (Figure 5B).